99 related articles for article (PubMed ID: 8082575)
21. [Adverse drug reactions. Hereditary differences in drug metabolism].
Collette D; Thürmann PA
Dtsch Med Wochenschr; 2002 May; 127(19):1025-8. PubMed ID: 11997871
[No Abstract] [Full Text] [Related]
22. Pan-fried meat containing high levels of heterocyclic aromatic amines but low levels of polycyclic aromatic hydrocarbons induces cytochrome P4501A2 activity in humans.
Sinha R; Rothman N; Brown ED; Mark SD; Hoover RN; Caporaso NE; Levander OA; Knize MG; Lang NP; Kadlubar FF
Cancer Res; 1994 Dec; 54(23):6154-9. PubMed ID: 7954461
[TBL] [Abstract][Full Text] [Related]
23. Interspecies metabolism of heterocyclic aromatic amines and the uncertainties in extrapolation of animal toxicity data for human risk assessment.
Turesky RJ
Mol Nutr Food Res; 2005 Feb; 49(2):101-17. PubMed ID: 15617087
[TBL] [Abstract][Full Text] [Related]
24. Characterization of the cytochrome P450 isozyme that metabolizes ochratoxin A, using metabolic inducers, inhibitors and antibodies.
Hietanen E; Bartsch H; Béréziat JC; Castegnaro M; Michelon J
IARC Sci Publ; 1991; (115):297-304. PubMed ID: 1820345
[TBL] [Abstract][Full Text] [Related]
25. Caffeine as a probe for CYP1A2 activity: potential influence of renal factors on urinary phenotypic trait measurements.
Tang BK; Zhou Y; Kadar D; Kalow W
Pharmacogenetics; 1994 Jun; 4(3):117-24. PubMed ID: 7920691
[TBL] [Abstract][Full Text] [Related]
26. Human cytochromes P4501A1 and P4501A2: R-warfarin metabolism as a probe.
Zhang Z; Fasco MJ; Huang Z; Guengerich FP; Kaminsky LS
Drug Metab Dispos; 1995 Dec; 23(12):1339-46. PubMed ID: 8689941
[TBL] [Abstract][Full Text] [Related]
27. [Human biodiversity and its effects on the pharmacological variability: CYP2D6 and NAT2 enzymes in Amerind populations of Panama, Colombia and Costa Rica].
Jorge LF; Arias TD
Rev Med Panama; 1995 Sep; 20(3):98-107. PubMed ID: 8668827
[TBL] [Abstract][Full Text] [Related]
28. Polymorphism of selected enzymes involved in detoxification and biotransformation in relation to lung cancer.
Gresner P; Gromadzinska J; Wasowicz W
Lung Cancer; 2007 Jul; 57(1):1-25. PubMed ID: 17337085
[TBL] [Abstract][Full Text] [Related]
29. [Study of the molecular mechanism of human cytochrome P450 and genetic polymorphism of drug oxidative metabolizing enzyme].
Zhao L; Lou YQ
Sheng Li Ke Xue Jin Zhan; 1997 Jan; 28(1):35-40. PubMed ID: 10921075
[TBL] [Abstract][Full Text] [Related]
30. Effects of ALDH2, CYP1A1, and CYP2E1 genetic polymorphisms and smoking and drinking habits on toluene metabolism in humans.
Kawamoto T; Koga M; Murata K; Matsuda S; Kodama Y
Toxicol Appl Pharmacol; 1995 Aug; 133(2):295-304. PubMed ID: 7645026
[TBL] [Abstract][Full Text] [Related]
31. The biochemistry of drug metabolism--an introduction: part 6. Inter-individual factors affecting drug metabolism.
Krämer SD; Testa B
Chem Biodivers; 2008 Dec; 5(12):2465-578. PubMed ID: 19089818
[TBL] [Abstract][Full Text] [Related]
32. Assessment of exposure and susceptibility to aromatic amine carcinogens.
Kadlubar FF; Talaska G; Lang NP; Benson RW; Roberts DW
IARC Sci Publ; 1988; (89):166-74. PubMed ID: 3198199
[TBL] [Abstract][Full Text] [Related]
33. Individuality in cytochrome P450 expression and its association with the nephrotoxic and carcinogenic effects of chemicals.
Wolf CR
IARC Sci Publ; 1991; (115):281-7. PubMed ID: 1820342
[TBL] [Abstract][Full Text] [Related]
34. Pharmacogenetics of cytotoxic drugs.
Daly AK; Hall AG
Expert Rev Anticancer Ther; 2001 Aug; 1(2):301-8. PubMed ID: 12113035
[TBL] [Abstract][Full Text] [Related]
35. Low CYP1A2 activity in rural Shona children of Zimbabwe.
Masimirembwa CM; Beke M; Hasler JA; Tang BK; Kalow W
Clin Pharmacol Ther; 1995 Jan; 57(1):25-31. PubMed ID: 7828378
[TBL] [Abstract][Full Text] [Related]
36. Caffeine phenotyping of cytochrome P4501A2, N-acetyltransferase, and xanthine oxidase in patients with familial adenomatous polyposis.
Spigelman AD; Farmer KC; Oliver S; Nugent KP; Bennett PN; Notarianni LJ; Dobrocky P; Phillips RK
Gut; 1995 Feb; 36(2):251-4. PubMed ID: 7883225
[TBL] [Abstract][Full Text] [Related]
37. Pharmacogenetic phenotyping and genotyping. Present status and future potential.
Gonzalez FJ; Idle JR
Clin Pharmacokinet; 1994 Jan; 26(1):59-70. PubMed ID: 8137598
[TBL] [Abstract][Full Text] [Related]
38. Verapamil and drug metabolism by the cytochrome P450 isoform CYP1A2.
Fuhr U; Woodcock BG; Siewert M
Eur J Clin Pharmacol; 1992; 42(4):463-4. PubMed ID: 1516612
[No Abstract] [Full Text] [Related]
39. Expression of cytochrome P450 and microsomal exposide hydrolase in cervical and oral epithelial cells immortalized by human papillomavirus type 16 E6/E7 genes.
Farin FM; Bigler LG; Oda D; McDougall JK; Omiecinski CJ
Carcinogenesis; 1995 Jul; 16(7):1670. PubMed ID: 7614706
[No Abstract] [Full Text] [Related]
40. Genes encoding drug-metabolizing enzymes: possible role in human disease.
Nebert DW
Basic Life Sci; 1988; 43():45-64. PubMed ID: 2896496
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
